Systems pharmacology integrates principles derived from pharmacology, bioinformatics, and systems biology to comprehensively elucidate the intricate interactions occurring between drugs and biological systems. This interdisciplinary field employs a systematic analysis of drug effects across molecular, cellular, tissue, and organism levels, taking into account the interconnected networks of genes, proteins, and pathways. Through the utilization of computational models, cheminformatics, and high-throughput data, systems pharmacology aims to predict drug responses, discern potential off-target effects, and optimize therapeutic outcomes. This approach acknowledges the dynamic and adaptive nature of biological systems, providing a more precise representation of drug behavior in vivo. By integrating pharmacoepidemiology and pharmacovigilance data, systems pharmacology enhances our understanding of real-world drug utilization patterns and safety profiles. In essence, systems pharmacology not only transcends traditional reductionist approaches but also represents a paradigm shift towards a more holistic and data-driven era in pharmacological research. This integrative approach fosters a deeper exploration of pharmacotherapeutic strategies, emphasizing the importance of personalized medicine, polypharmacy considerations, and the optimization of drug combinations to address the complexities of diverse patient populations.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico